Microbubble disappearance-time is the appropriate timing for liver-specific imaging after injection of Levovist

Ultrasound in Medicine and Biology

Volumn 32, Issue 12, 2006, Pages 1809-1815

  Maruyama, Hitoshi ^a   Matsutani, Shoichi ^a   Okugawa, Hidehiro ^a   Kobayashi, Satoshi ^a   Yoshizumi, Hiroaki ^a   Ebara, Masaaki ^a   Saisho, Hiromitsu ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Contrast agent; Hepatocellular carcinoma; Levovist; Liver; Liver specific phase; Ultrasound

Indexed keywords

BIOLOGICAL ORGANS; CONTRAST MEDIA; DOPPLER EFFECT; DRUG DOSAGE; PATIENT TREATMENT; ULTRASONIC APPLICATIONS;

CONTRAST AGENTS; DOPPLER ULTRASONOGRAPHY; HEPATOCELLULAR CARCINOMA; LEVOVIST; LIVER; LIVER SPECIFIC PHASE;

MEDICAL IMAGING;

SHU 508;

ADULT; AGED; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; HEPATOGRAPHY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; MAJOR CLINICAL STUDY; MALE; MICROBUBBLE; PRIORITY JOURNAL; TIME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE ENHANCEMENT; INJECTIONS, INTRAVENOUS; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MICROBUBBLES; MIDDLE AGED; POLYSACCHARIDES; PORTAL VEIN; RETROSPECTIVE STUDIES; TIME FACTORS; ULTRASONOGRAPHY, DOPPLER;

EID: 33845309438     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2006.06.024     Document Type: Article

References (32)

1. Albrecht T., Blomley M.J., Cosgrove D.O., et al. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent. Lancet 353 (1999) 1579-1583
2. Barr R. Seeking consensus: Contrast ultrasound in radiology. Eur J Radiol 41 (2002) 207-216
3. Blomley M.J., Albrecht T., Cosgrove D.O., et al. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: Early experience. Radiology 210 (1999) 409-416
4. Blomley M.J., Lim A.K., Harvey C.J., et al. Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: A cross sectional study. Gut 52 (2003) 1188-1193
5. Brannigan M., Burns P.N., and Wilson S.R. Blood flow patterns in focal liver lesions at microbubble-enhanced US. Radiographics 24 (2004) 921-935
6. Bryant T.H., Blomley M.J., Albrecht T., et al. Improved characterization of liver lesions with liver-phase uptake of liver-specific microbubbles: prospective multicenter study. Radiology 232 (2004) 799-809
7. Burns P.N. Harmonic imaging with ultrasound contrast agents. Clin Radiol 51 suppl.1 (1996) 50-55
8. Cosgrove D., and Blomley M. Liver tumors: Evaluation with contrast-enhanced ultrasound. Abdom Imaging 29 (2004) 446-454
9. Forsberg F., Liu J.B., Merton D.A., Rawool N.M., Johnson D.K., and Goldberg B.B. Gray scale second harmonic imaging of acoustic emission signals improves detection of liver tumors in rabbits. J Ultrasound Med 19 (2000) 557-563
10. Forsberg F., Piccoli C.W., Liu J.B., et al. Hepatic tumor detection: MR imaging and conventional US versus pulse-inversion harmonic US of NC100100 during its reticuloendothelial system-specific phase. Radiology 222 (2002) 824-829
11. Goldberg B.B., Liu J.B., and Forsberg F. Ultrasound contrast agents: A review. Ultrasound Med Biol 20 (1994) 319-333
12. Harvey C.J., Blomley M.J., Eckersley R.J., Heckemann R.A., Butler-Barnes J., and Cosgrove D.O. Pulse-inversion mode imaging of liver specific microbubbles: Improved detection of subcentimetre metastases. Lancet 355 (2000) 807-808
13. Harvey C.J., Blomley M.J., Eckersley R.J., et al. Hepatic malignancies: Improved detection with pulse-inversion US in late phase of enhancement with SH U 508A-Early experience. Radiology 216 (2000) 903-908
14. Harvey C.J., Lim A.K., Blomley M.J., Taylor-Robinson S.D., Gedroyc W.M., and Cosgrove D.O. Detection of an occult hepatocellular carcinoma using ultrasound with liver-specific microbubbles. Eur Radiol 12 Suppl. 3 (2002) S70-S73
15. Inoue T., Kudo M., Watai R., et al. Differential diagnosis of nodular lesions in cirrhotic liver by post-vascular phase contrast-enhanced US with Levovist: Comparison with superparamagnetic iron oxide magnetic resonance images. J Gastroenterol 40 (2005) 1139-1147
16. Kaneko T., Teshigawara O., Sugimoto H., et al. Signal intensity of the liver parenchyma in microbubble contrast agent in the late liver phase reflects advanced fibrosis of the liver. Liver International 25 (2005) 288-293
17. Kim T.K., Choi B.I., Hong H., Choi B.Y., and Han J.K. Improved imaging of hepatic metastases with delayed pulse inversion harmonic imaging using a contrast agent SH U 508A: Preliminary study. Ultrasound Med Biol 26 (2000) 1439-1444
18. Kitamura H., Kawasaki S., Nakajima K., and Ota H. Correlation between microbubble contrast-enhanced color Doppler sonogaphy and immunostaining for Kupffer cells in assessing the histopathologic grade of hepatocellular carcinoma: Preliminary results. J Clin Ultrasound 30 (2002) 465-471
19. Kono Y., Steinbach G.C., Peterson T., Schmid-Schonbein G.W., and Mattrey R.F. Mechanism of parenchymal enhancement of the liver with a microbubble-based US contrast medium: An intravital microscopy study in rats. Radiology 224 (2002) 253-257
20. Kontos H.A., Shapiro W., Mauck H.P., and Patterson Jr. J.L. General and regional circulatory alterations in cirrhosis of the liver. Am J Med 37 (1964) 526-535
21. Lautt W.W., Legare D.J., and Ezzat W.R. Quantitation of the hepatic arterial buffer response to graded changes in portal blood flow. Gastroenterology 98 (1990) 1024-1028
22. Lim A.K., Patel N., Eckersley R.J., Taylor-Robinson S.D., Cosgrove D.O., and Blomley M.J. Evidence for spleen-specific uptake of a microbubble contrast agent: a quantitative study in healthy volunteers. Radiology 231 (2004) 785-788
23. Maruyama H., Matsutani S., Saisho H., Mine Y., Yuki H., and Miyata K. Different behaviors of microbubbles in the liver: Time-related quantitative analysis of two ultrasound contrast agents, Levovist and Definity. Ultrasound Med Biol 30 (2004) 1035-1040
24. Maruyama H., Matsutani S., Saisho H., et al. Real-time blood-pool images of contrast enhanced ultrasound with Definity in the detection of tumour nodules in the liver. Br J Radiol 78 (2005) 512-518
25. Migaleddu V., Virgilio G., Turilli D., et al. Characterization of focal liver lesions in real time using harmonic imaging with high mechanical index and contrast agent Levovist. Am J Roentgenol 182 (2004) 1505-1512
26. Murray J.F., Dawson A.M., and Sherlock S. Circulatory changes in chronic liver disease. Am J Med 24 (1958) 358-367
27. Pugh R.N.H., Murray-Lyon I.M., Dawson J.L., Pietroni M.C., and Williams R. Transection of the esophagus for bleeding esophageal varices. Br J Surg 60 (1973) 646-649
28. Ricci P., Laghi A., Cantisani V., et al. Contrast-enhanced sonography with SonoVue: Enhancement patterns of benign focal liver lesions and correlation with dynamic gadobenate dimeglumine-enhanced MRI. Am J Roentgenol 184 (2005) 821-827
29. Richter S., Mücke I., Menger M.D., and Vollmar B. Impact of intrinsic blood flow regulation in cirrhosis: Maintenance of hepatic arterial buffer response. Am J Physiol 279 (2000) G454-G462
30. Sugimoto H., Kaneko T., Hirota M., Tezel E., and Nakao A. Earlier hepatic vein transit-time measured by contrast ultrasonography reflects intrahepatic hemodynamic changes accompanying cirrhosis. J Hepatol 37 (2002) 578-583
31. von Herbay A., Vogt C., Willers R., and Haussinger D. Real-time imaging with the sonographic contrast agent SonoVue: Differentiation between benign and malignant hepatic lesions. J Ultrasound Med 23 (2004) 1557-1568
32. von Herbay A., Vogt C., and Haussinger D. Late-phase pulse-inversion sonography using the contrast agent Levovist: Differentiation between benign and malignant focal lesions of the liver. Am J Roentgenol 179 (2002) 1273-1279